
Can Spermidine Protect Cancer Patients From Radiation Damage? (New Study) 089
In this episode of the RevGenetics podcast, Les and Amy dive into a promising breakthrough in cancer supportive care: how a natural compound called spermidine may protect cancer patients from severe dry mouth (xerostomia) caused by radiation therapy. Radiation therapy often damages salivary glands, leading to debilitating long-term side effects for patients. A recent study reveals that supplementing with spermidine post-radiation helps safeguard submandibular gland function and promote recovery. By mitigating these harsh consequences, spermidine opens up an exciting new avenue for improving the quality of life for individuals undergoing cancer treatment. Join us as we unpack the mechanism behind this discovery and its real-world implications for patient wellness and healthy recovery. Supported by RevGenetics – Science-Based Supplements For Healthy Aging 👉 Explore Longevity Products Referenced Study: 🔗 Oral Spermidine Supplementation Preserves Submandibular Gland Function After Radiotherapy: Mechanistic Insights and Use in a Phase II Randomized Clinical Trial #Spermidine #RadiationTherapy #Xerostomia #CancerSupport #RevGenetics #DryMouthRelief #SalivaryGlandHealth #RevGeneticsPodcast #ClinicalTrial #HealthyAging #SupportiveCare #MedicalResearch #NaturalCompounds #QualityOfLife #OncologyResearch #CellularHealth #SpermidineStudy #CancerRecovery #ScienceBreakthroughs #RevGeneticsSupport